Seizure outcome trajectories in a well‐defined cohort of newly diagnosed juvenile myoclonic epilepsy patients
- 17 November 2021
- journal article
- research article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 145 (3) , 314-321
Abstract
Objective To investigate the temporal course of medication response and associated prognostic factors in a cohort of juvenile myoclonic epilepsy (JME) patients over a long-term follow-up. Materials and Methods Data from 113 JME patients diagnosed according to recently proposed class II criteria were retrospectively reviewed. Early sustained remission was defined as 4-year seizure remission starting within 2 years from the first antiseizure medication (ASM) intake, as opposed to delayed sustained remission. Spontaneous relapse rate (ie, not related to ASM withdrawal) was also investigated, along with factors associated with seizure relapse. Results Four-year seizure remission was obtained by 76/113 (67.3%) subjects. Early sustained remission was achieved by 45/76 (59.2%) patients. Absence seizures were significantly associated with no-remission at multivariable multinomial logistic regression analysis. Catamenial seizures and earlier age at epilepsy onset significantly predicted delayed sustained remission. Spontaneous seizure relapse after 4-year remission occurred in 15.7% of patients with early sustained remission and in 35.5% of those with delayed sustained remission (p = 0.045). The most common concomitant factors for a spontaneous relapse were irregular lifestyle habits and pregnancy-related switch from valproate to another ASM. Patients with a history of catamenial seizures were more likely to experience a spontaneous generalized tonic-clonic seizure relapse after 4-year remission at univariable analysis. Significance Our data support the prognostic relevance of early medication response in JME patients. Furthermore, the prognostic significance of catamenial seizures and the impact of valproate switch on seizure relapse after a prolonged remission account for the challenging therapeutic management of women with childbearing potential.Keywords
This publication has 42 references indexed in Scilit:
- Clinical course and seizure outcome of idiopathic childhood epilepsy: determinants of early and long-term prognosisBMC Neurology, 2013
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesEpilepsia, 2010
- Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsyNeurology, 2008
- Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-upBrain, 2006
- Two‐Year Remission and Subsequent Relapse in Children with Newly Diagnosed EpilepsyEpilepsia, 2001
- Clinical factors of drug resistance in juvenile myoclonic epilepsyJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Juvenile Myoclonic Epilepsy: A 5‐Year Prospective StudyEpilepsia, 1994
- Phenytoin Levels in Catamenial EpilepsyEpilepsia, 1988
- Epilepsy with impulsive petit mal (Juvenile Myoclonic Epilepsy)Acta Neurologica Scandinavica, 1985
- Remission of Seizures and Relapse in Patients with EpilepsyEpilepsia, 1979